Our latest in a series of Research Roundtables, held in 5 cities throughout the U.S. in 2011, was held in New York on November 12th with over 150 participants in attendance. The topic of the Roundtable was MJFF’s Purpose, Promise and Plan for speeding new Parkinson’s treatments to patients. The panel speakers included:

• Deborah W. Brooks, The Michael J. Fox Foundation for Parkinson’s Research
• Todd Sherer, PhD, The Michael J. Fox Foundation for Parkinson’s Research
• Anders Björklund, MD, PhD, Lund University
• John Dunlop, PhD, Pfizer, Inc., Neuroscience Research Unit
• Mark Frasier, PhD, The Michael J. Fox Foundation for Parkinson’s Research

In addition to the panelists we also had several scientist in the audience to help answer questions during the Q&A session:

• Irene Hegemen Richard, MD, University of Rochester
• Peter Reinhart, PhD, Proteostasis
• Andrew Singleton, PhD, National Institute on Aging/NIH

I was tweeting during the 2 hour session. Here are the tweets for the Q&A portion:

 

Q&A, Irene Hegemen Richard, MD, Univ. of Rochester, exercise (that u can stick w/) & heart healthy diet important for #Parkinsons patients
Q&A, Dr. Richard, MJFF also funding research on acupuncture to help #Parkinsons patients with fatigue
Q&A, Mark Frasier, PPMI groundbreaking initiative to identify #Parkinsons biomarker, already yielding data, still recruiting patients
Q&A, Todd Sherer, hope that recent promising #StemCell paper in Nature on #parkinsons will lead to progress in dopamine centered research
Q&A, Debi Brooks, we just reached the $20M mark on way to 2 year $50M Brin-Wojcicki matching challene. We still need your help to fully earn
Q&A, Dr. Richard, explains Deep Brain Stimulation, electrical stimulation mimics dopamine, not disease modifying but can last 10 yrs

And here is the full presentation from the roundtable:
MJFF’s Purpose, Promise and Plan for speeding new Parkinson’s treatments to patients

View more presentations from Laxmi Wordham